- Home
- About Us
- Our Research
- Support Us
- Why support QIMR?
- Ways you can help us
- Donate Now
- Join the Rio Tinto Ride to Conquer Cancer
- Join our Regular Giving Club
- Join the Weekend to End Women's Cancers
- Leave a bequest in your will
- Purchase Christmas cards and hampers
- Corporate partnerships
- Workplace giving
- Fundraise for QIMR
- Attend a fundraising event
- Tribute gifts
- In memoriam gifts
- Stories of hope
- Book a tour or guest speaker
- Our supporters
- Thanks to our donors
- Students
- News & Events
- Careers
- Contact Us
- QSkin
- CMV study
- Queensland Pancreatic Cancer Study
- Australian Centre for Vaccine Development
| Share on Facebook | Share on Twitter | Share on LinkedIn |
Leishmaniasis is a disease that occurs in tropical and sub-tropical countries. It is caused by a protozoan parasite (from the genus Leishmania) and is transmitted by phlebotomine sandflies.
There is no vaccine against leishmaniasis, and treatment requires long courses of toxic drugs, to which the parasites have started to develop resistance.
QIMR aims to develop therapies that work in tandem to current treatments or that will replace them entirely.
Our research focuses on:
- Understanding how the leishmaniasis parasite evades the immune response.
- Identifying ways to boost anti-parasitic immunity by utilising the body's natural defences.
Research group involved in leishmaniasis research:
